Anti-PD-1 (J43)

Anti-PD-1 [J43], Recombinant, IgG2a lambda, Mouse
Artikelnummer
ABAAb01417-2.3-VXF
Verpackungseinheit
50 mg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: J43

Heavy Chain modification: Fc Silent™

Antigen Long Description: This antibody was raised by immunising Armenian hamsters with B12 cells, a PD-1 cDNA transfectant of BHK cells.

Buffer Composition: PBS only.

Chimeric Use Statement: This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

Uniprot Accession No.: Q02242

Specificity Statement: This antibody is specific for murine PD-1.

Application Notes (Clone): The specificity of this antibody has been confirmed in ELISA analysis, using PD-1 extracellular domain fusion proteins (Agata et al, 1996). Additionally, in flow cytometric analysis, this antibody reacts with PD-1 cDNA-transfected BHK and CHO cells, but not with parental BHK and CHO cells, as well as reacting with lymphocytes from PD-1 cDNA transgenic mice (Agata et al, 1996). This antibody has been used to immunoprecipitate PD-1 from lysates of PD-1 cDNA-transfected BHK and CHO cells (Agata et al, 1996), in flow cytometric quantification of CD4+PD-1+ T cells in murine spleens (Kasagi et al, 2010), and in immunohistochemical analysis of acetone-fixed murine spinal cord and brain tissue sections (Salama et al, 2003). This antibody displays diverse effects in different mouse models of disease. When administered to NZB/W F1 mice, a model of lupus-like nephritis, this antibody has been shown to delay the onset of nephritis and prolong survival, through the depletion of PD-1+ T cells (Kasagi et al, 2010). Antibody-treated NZB/W F1 mice displayed decreased numbers of PD-1+ T cells, and this antibody was confirmed to trigger complement-dependent cytotoxicity in PD-1+ T cells in vitro (Kasagi et al, 2010). Conversely, administration to experimental allergic encephalitis (EAE) and NOD diabetes mice exacerbated disease, through its neutralising activity (Salama et al, 2003; Ansari et al, 2003); this antibody has been shown in vitro to inhibit binding of both PD-L1-Ig and PD-L2-Ig to PD-1 transfected BHK cells (Ansari et al, 2003).
Mehr Informationen
Artikelnummer ABAAb01417-2.3-VXF
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab01417-2.3-VXF
Verpackungseinheit 50 mg
Mengeneinheit STK
Reaktivität Mouse (Murine)
Klonalität Recombinant
Methode Immunoprecipitation, ELISA, Flow Cytometry, Immunohistochemistry, Neutralization
Isotyp IgG2a lambda
Wirt Mouse
Produktinformation (PDF) Download
MSDS (PDF) Download